Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export andsupplier ofCarmustine for Injectionfrom Surat, Gujarat, India. Carmustine forInjection used mainly for chemotherapy. It is a nitrogen mustard-chloro-nitrosourea compound used as an alkylating agent.
Tags: Carmustine for Injection manufacturer, Carmustine forInjection exporter, Carmustine for Injection supplier, and Carmustine forInjection, whogmp approved Carmustine for Injection manufacturer and supplier, Carmustine ForInjection distributor, Carmustine for Injection shipper, Carmustine forInjection 10 ml Carmustine for Injection 10 mlsupplier,Carmustine for Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Carmustine forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
How Carmustine for Injection WorksCarmustine, a cytotoxic agent, works by interfering with the growth of cancer cells, slowing or stopping their replication. It is particularly useful in treating certain types of brain tumors, as well as Hodgkin's and non-Hodgkin's lymphomas, and multiple myeloma. Its effectiveness is based on its capacity to damage the DNA of rapidly dividing cancerous cells.
Process of Administration and ReconstitutionBefore administration, Carmustine for Injection must be reconstituted with the provided diluent following the physician's instructions. The resulting solution is then infused intravenously in a clinical setting. Only trained healthcare professionals familiar with cytotoxic chemotherapy should handle and administer this medication due to its hazardous nature.
Storage, Handling, and Safety PrecautionsThis medication should be stored in a cool, dry place, protected from direct sunlight. As a cytotoxic drug, Carmustine must be handled with care by professionals using protective equipment. The single-use vial should be disposed of properly after use, ensuring safety for both patients and medical staff.
FAQ's of Carmustine For Injection:
Q: How should Carmustine for Injection be prepared before administration?
A: Carmustine for Injection must be reconstituted with the supplied diluent according to the manufacturer's instructions before being administered as an intravenous infusion. This preparation should only be performed by qualified healthcare professionals.
Q: What is the primary use of Carmustine for Injection?
A: Carmustine for Injection is primarily indicated for the treatment of certain brain tumors, multiple myeloma, Hodgkin's lymphoma, and non-Hodgkin's lymphoma in adult and pediatric patients, under physician supervision.
Q: When and how is Carmustine for Injection administered?
A: After reconstitution, Carmustine is given as a slow intravenous infusion in a clinical or hospital environment. The timing and frequency are determined by the prescribing physician based on the patient's diagnosis and health status.
Q: Where should Carmustine for Injection be stored after purchase?
A: The vials should be stored in a cool, dry place according to the product's label instructions. Once reconstituted, any unused solution must be discarded, as the vial is intended for single use only.
Q: What are the safety precautions when handling Carmustine for Injection?
A: As a cytotoxic medication, Carmustine should be handled with appropriate protective equipment by trained staff. It must only be administered under the supervision of a physician experienced in cytotoxic chemotherapy due to its potent effects and potential hazards.
Q: Is Carmustine for Injection compatible with 5% dextrose solution for infusion?
A: Yes, Carmustine for Injection is compatible with 5% dextrose solution, in accordance with the instructions for administration provided with the medication.
Q: What is the benefit of using Carmustine for Injection in cancer treatment?
A: Carmustine is effective in targeting and destroying certain types of cancer cells, making it a valuable therapy for aggressive malignancies such as specific brain tumors, and lymphomas. Its use can help control tumor growth and improve patient outcomes under appropriate medical supervision.